Retinopathy News and Research

RSS

$Study finds increase in prevalence of nonrefractive visual impairment in the U.S.$

Study finds increase in prevalence of nonrefractive visual impairment in the U.S.

The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.

12 Dec 2012

New €6 million European project to address complications associated with diabetes

NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.

19 Nov 2012

Hospital quality may affect infant morbidity

Birth in or postnatal transfer to hospitals with a lower level of resources and facilities may negatively impact the health of very preterm infants, show research findings.

6 Nov 2012

HbA1c equally useful across ethnic groups

Currently recommended clinical cutoff points for diabetes diagnosis using glycated hemoglobin should be interpreted similarly in Whites, Blacks, and Hispanics, show findings from a US study.

26 Oct 2012

HbA1c equally useful across ethnic groups

Currently recommended clinical cutoff points for diabetes diagnosis using glycated hemoglobin should be interpreted similarly in Whites, Blacks, and Hispanics, show findings from a US study.

25 Oct 2012

Perimetry identifies visual function changes in diabetic retinopathy

Perimetry could be adopted as a method to measure changes in visual function among individuals with diabetic retinopathy, show promising results from a prospective longitudinal study undertaken in Sweden.

12 Oct 2012

Transfused blood age does not impact outcomes in premature babies

Using fresh red blood cells for premature babies who need blood transfusions does not improve outcomes over use of standard blood bank donations, show study findings published in JAMA.

9 Oct 2012

Time is of the essence in depressed diabetes patients

Among patients with diabetes and comorbid depression, the time point at which they developed depression may have important implications for their clinical management, say researchers.

5 Oct 2012

Cost of glaucoma revealed

The first 6 months after an open-angle glaucoma diagnosis are the most costly within the first 2 years of having the condition, report US researchers.

26 Sep 2012

Universitat de València to use optical technology to prevent myopia

The Universitat de València will use optical technology in order to prevent myopia, which is considered the most common eye disease in the world. Until now, this technology was only used in astronomy to study images of the Universe.

26 Sep 2012

Weill Cornell to purchase innovative equipment to help detect and treat diabetic retinopathy

Weill Cornell Medical College's ophthalmology services for diabetic patients received a boost last month, courtesy of a grant from the New York City Council secured by Councilwoman Jessica Lappin.

21 Sep 2012

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

Aerpio Therapeutics, a clinical-stage biopharmaceutical company developing innovative therapies for vascular diseases by targeting the Tie2 pathway, today announced that it has dosed the first patient in a Phase 1b/2a trial of AKB-9778 for the treatment of diabetic macular edema (DME).

20 Sep 2012

Age at diabetes onset linked to macular edema onset

Older age at onset of Type 1 diabetes significantly increases the risk for developing clinically significant macular edema, show study findings.

19 Sep 2012

Factors predictive of successful DME treatment revealed

The pretreatment central subfield thickness in the eyes of patients with diabetic macular edema is the strongest predictor of outcome after one year of treatment with ranibizumab, with a reduction linked to better visual acuity outcomes, report researchers.

14 Sep 2012

Local Talent Global Impact event at Queen's University to be held on Sep. 13

Members of the public are being invited to Queen's University at lunchtime on Thursday (13 September) to meet and hear from the people behind some of the biggest scientific, medical and technological breakthroughs of recent times.

13 Sep 2012

Joslin Diabetes Center, Mass. Eye and Ear partner to form clinical and research alliance

Massachusetts Eye and Ear and the Joslin Diabetes Center announced today that they have reached agreement to form a clinical and research alliance, aimed toward providing coordinated high quality care to eye patients throughout greater Boston, especially those with or at-risk for diabetes-related eye disease.

11 Sep 2012

Combining two drugs may offer new and potent punch against cancer and other diseases

A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal -- such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.

11 Sep 2012

Useful vision maintained long term after lens-sparing vitrectomy for ROP

Infants treated with lens-sparing vitrectomy for retinopathy of prematurity maintain a level of visual acuity necessary for useful vision into their eighth year of life, study results show.

31 Aug 2012

'ESASO Course Series’ for ophthalmologists

In the new book series 'ESASO Course Series', the essentials of the courses of the European School for Advanced Studies in Ophthalmology (ESASO) are made available to interested ophthalmologists, optometrists, technicians and residents all over the world.

23 Aug 2012

Vision symptoms plus retinal changes trigger need for AMD intervention

An analysis of over 1000 individuals presenting with suspected exudative age-related macular degeneration has revealed which factors are most predictive of the need for treatment.

22 Aug 2012